BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 22
• 23
• 24
• 25
• 26
• 27
• 30
• 31

• Deals

  Biopharma Company Endocyte, Inc. Files Plan For $86.3 Mln IPO

  August 18, 2010

   · 

  1 min read
• Business

  Quark Pharmaceuticals Inc., Novartis Corporation Sign $670-Mln Drug Deal

  August 18, 2010

   · 

  3 min read
• Policy

  Jazz Pharmaceuticals, Inc.'s Fibromyalgia Drug With Date-Rape Chemical Safe, Effective, FDA Says

  August 18, 2010

   · 

  1 min read
• Deals

  Stryker Corporation Eyes $1.5B Boston Scientific Corporation Unit

  August 18, 2010

   · 

  1 min read
• Deals

  China Orders Divestitures before Novartis AG-Alcon, Inc. Merger

  August 18, 2010

   · 

  1 min read
• Business

  Limerick BioPharma Inc. Names Jill Carroll to Serve as Vice President of Strategic Corporate Development

  August 18, 2010

   · 

  1 min read
• Business

  CEVEC Pharma Signs Global License Agreement for Human CAP-T Technology with CEVEC Pharma

  August 18, 2010

   · 

  3 min read
• BioMidwest

  Bolder BioTechnology, Inc. Announces $600,000 Grant from National Institutes of Health (NIH) to Study Long-Acting IL-11 Analog in Treating Acute Radiation Syndrome

  August 18, 2010

   · 

  2 min read
• Business

  Innovotech Inc. Reports Second Quarter 2010 Financial Results

  August 18, 2010

   · 

  4 min read
• Drug Development

  ImmunoGen, Inc. Announces Orphan Drug Designation Granted to Lorvotuzumab Mertansine for Treatment of Small-Cell Lung Cancer

  August 18, 2010

   · 

  1 min read